Argosy Investors adds DAVA, FND; exits NVO in Q4
Source: SeekingAlpha
2026-03-09 15:25:39 ET
More on Novo Nordisk A/S
- CagriSema Incident: The Surprise Winner And What It Means For The Novo-Lilly Rivalry
- Pricing Pressure And Panic: What The Market May Be Missing In Novo Nordisk
- Eli Lilly Vs. Novo Nordisk: The Valuation Gap Is Unreasonable
- Novo’s China obesity drug posts positive mid-stage trial results
- Novo Nordisk board proposes DKK 7.95 final dividend for 2025, initiates DKK 15B buyback
Read the full article on Seeking Alpha
For further details see:
Argosy Investors adds DAVA, FND; exits NVO in Q4
Endava plc American Depositary Shares
NASDAQ: DAVA
DAVA Trading
-1.84% G/L:
$4.795 Last:
155,092 Volume:
$4.87 Open:
DAVA Latest News
DAVA Stock Data
$305,592,767
53,784,327
N/A
32
N/A
Software & IT Services
Technology
GB
London
